520
Draft Red Herring Prospectus November 5, 2018 Please read Section 32 of the Companies Act, 2013 This Draft Red Herring Prospectus will be updated upon, filing the Red Herring Prospectus with ROC Book Built Offer NEOGEN CHEMICALS LIMITED Our Company was incorporated as ‘Neogen Chemicals Private Limited’ on March 7, 1989, at Thane, Maharashtra as a private limited company under the Companies Act, 1956 and received a certificate of incorporation from the Registrar of Companies, Mumbai, Maharashtra. Subsequently, pursuant to a special resolution passed by the shareholders of our Company on May 2, 1998, our Company was converted to a public limited company and the name of our Company was changed to Neogen Chemicals Limited, and a fresh certificate of incorporation dated July 2, 1998 was issued to our Company by the Registrar of Companies, Mumbai, Maharashtra. For further details, please refer to the chapter History and Certain Corporate Matters’ on page 166. Registered and Corporate Office: 1002, 10 th Floor, Dev Corpora Bldg, Opp. Cadbury Junction, Off Pokhran Road No. 2, Khopat, Thane - 400 601, Maharashtra, India; Tel: +91 22 2549 7300; Fax: +91 22 2549 7399; Corporate Identity Number: U24200MH1989PLC050919; Email: [email protected]; Website: www.neogenchem.com; Contact Person: Lalit Ashok Karne, Company Secretary and Compliance Officer; Tel: +91 22 2549 7300; Fax: +91 22 2549 7399; Email: [email protected] PROMOTERS OF OUR COMPANY: HARIDAS THAKARSHI KANANI AND HARIN HARIDAS KANANI INITIAL PUBLIC OFFER OF UP TO [●] EQUITY SHARES OF FACE VALUE OF ₹10 EACH (EQUITY SHARES) OF NEOGEN CHEMICALS LIMITED (OUR COMPANY) FOR CASH AT A PRICE OF ₹ [•] PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF ₹ [•] PER EQUITY SHARE) AGGREGATING UP TO ₹ [•] MILLION (OFFER). THE OFFER COMPRISES OF A FRESH ISSUE OF UP TO [•] EQUITY SHARES AGGREGATING UP TO ₹ 700.00 MILLION BY OUR COMPANY (FRESH ISSUE) AND AN OFFER FOR SALE OF UP TO 1,699,600 EQUITY SHARES BY HARIDAS THAKARSHI KANANI (SELLING SHAREHOLDER 1) AND UP TO 1,200,400 EQUITY SHARES BY BEENA HARIDAS KANANI (SELLING SHAREHOLDER 2’, AND ALONG WITH SELLING SHAREHOLDER 1 COLLECTIVELY REFERRED TO AS THE ‘SELLING SHAREHOLDERS’) AGGREGATING UP TO ₹[•] MILLION (OFFER FOR SALE). THE OFFER SHALL CONSTITUTE [•]% OF THE POST-OFFERED PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY. THE FACE VALUE OF THE EQUITY SHARES IS ₹10 EACH AND THE OFFER PRICE IS [•] TIMES THE FACE VALUE OF THE EQUITY SHARES. THE PRICE BAND AND THE MINIMUM BID LOT WILL BE DECIDED BY OUR COMPANY AND THE SELLING SHAREHOLDERS IN CONSULTATION WITH THE BOOK RUNNING LEAD MANAGER (BRLM) AND THE CO-BOOK RUNNING LEAD MANAGER (CBRLM) AND WILL BE ADVERTISED IN ALL EDITIONS OF [●], [●] AND [●] (WHICH ARE WIDELY CIRCULATED DAILY ENGLISH, HINDI AND MARATHI NEWSPAPERS, RESPECTIVELY, MARATHI BEING THE REGIONAL LANGUAGE OF MAHARASHTRA, WHERE OUR REGISTERED OFFICE IS LOCATED), AT LEAST 5 WORKING DAYS PRIOR TO THE BID/OFFER OPENING DATE AND SHALL BE MADE AVAILABLE TO BSE LIMITED (BSE) AND THE NATIONAL STOCK EXCHANGE OF INDIA LIMITED (‘NSE, AND TOGETHER WITH BSE REFERRED TO AS THE STOCK EXCHANGES) FOR THE PURPOSES OF UPLOADING ON THEIR RESPECTIVE WEBSITES. In case of any revisions in the Price Band, the Bid/Offer Period will be extended by at least 3 additional Working Days after such revision of the Price Band, subject to the Bid/Offer Period not exceeding 10 Working Days. Any revision in the Price Band and the revised Bid/Offer Period, if applicable, will be widely disseminated by notification to the Stock Exchanges, by issuing a press release, and also by indicating the change on the website of the BRLM and CBRLM and the terminals of the Syndicate Members and intimation to Self Certified Syndicate Banks (SCSB), Registered Brokers, Collecting Depository Participants (CDP) and Registrar to the Issue and Share Transfer Agent (RTA) (and together with the SCSBs, Registered Brokers and CDPs the Registered Intermediary). This Offer is being undertaken in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (SCRR) read with Regulation 41 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, as amended (SEBI ICDR Regulations). The Offer is being made through the Book Building Process in accordance with Regulation 26(1) of the SEBI ICDR Regulations, wherein not more 50% of the Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (QIBs) (QIB Portion), provided that our Company may, in consultation with the BRLM and CBRLM, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations (Anchor Investor Portion), out of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price. Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIBs (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Offer Price. Further, not less than 15% of the Offer shall be available for allocation on a proportionate basis to Non-Institutional Investors and not less than 35% of the Offer shall be available for allocation on a proportionate basis to Retail Individual Investors in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price. All Bidders, other than Anchor Investors, shall participate in the Offer mandatorily through the Applications Supported by Blocked Amount (ASBA) process by providing the details of their respective bank accounts in which the corresponding Bid Amount will be blocked by the SCSBs. Anchor Investors are not permitted to participate in the Offer through the ASBA process. For details, please refer to the chapter ‘Offer Procedure’ on page 442. RISKS IN RELATION TO THE FIRST OFFER This being the first public issue of Equity Shares of our Company, there has been no formal market for the Equity Shares. The face value of the Equity Shares is 10 each. The Floor Price is [●] times the face value of Equity Shares and the Cap Price is [●] times the face value of Equity Shares. The Offer Price (determined and justified by our Company and the Selling Shareholders, in consultation with the BRLM and the CBRLM as stated in Basis for Offer Priceon page 107 ) should not be taken to be indicative of the market price of the Equity Shares after the Equity Shares are listed. No assurance can be given regarding an active or sustained trading in the Equity Shares or regarding the price at which the Equity Shares will be traded after listing. GENERAL RISKS Investments in equity and equity-related securities involve a degree of risk and investors should not invest any funds in this Offer unless they can afford to take the risk of losing their entire investment. Investors are advised to read the risk factors carefully before taking an investment decision in this Offer. For taking an investment decision, investors must rely on their own examination of our Company and the Offer, including the risks involved. The Equity Shares offered in the Offer have not been recommended or approved by the Securities and Exchange Board of India (SEBI), nor does SEBI guarantee the accuracy or adequacy of the contents. Specific attention of the investors is invited to the section Risk Factorson page 17. COMPANY’S AND SELLING SHAREHOLDERSABSOLUTE RESPONSIBILITY Our Company, having made all reasonable inquiries, accepts responsibility for and confirms that this Draft Red Herring Prospectus contains all information with regard to our Company and the Offer, which is material in the context of the Offer, that the information contained in this Draft Red Herring Prospectus is true and correct in all material aspects and is not misleading in any material respect, that the opinions and intentions expressed herein are honestly held and that there are no other facts, the omission of which makes this Draft Red Herring Prospectus as a whole or any of such information or the expression of any such opinions or intentions, misleading in any material respect. Each Selling Shareholder accepts responsibility only for the statements in this Draft Red Herring Prospectus specifically made or confirmed with respect to themselves and the Equity Shares offered by them in the Offer for Sale and confirms that such statements are true and correct in all material respects and are not misleading in any material respect. LISTING The Equity Shares offered in the Offer through the Red Herring Prospectus are proposed to be listed on the BSE and the NSE. In-principle approvals of BSE and NSE for listing the Equity Shares have been received pursuant to letter dated [●] and letter dated [●], respectively. For the purposes of the Offer, the Designated Stock Exchange shall be [●]. A signed copy of the Red Herring Prospectus and the Prospectus shall be delivered for registration to the RoC in accordance with the Companies Act, 2013. For details of the material contracts and documents available for inspection from the date of the Red Herring Prospectus up to the Bid/Offer Closing Date. For details, please refer to the chapter ‘Material Contracts and Documents for Inspectionon page 515. BOOK RUNNING LEAD MANAGER CO-BOOK RUNNING LEAD MANAGER REGISTRAR TO THE OFFER INGA ADVISORS PRIVATE LIMITED 1229, Hubtown Solaris, N.S. Phadke Marg, Opp. Telli Galli, Andheri (E) - 400 069, Mumbai, Maharashtra, India Telephone: +91 22 2681 6003 Facsimile: +91 22 2681 6020 Email: [email protected] Investor Grievance Email: [email protected] Website: www.ingaadvisors.com Contact Person Details: Kavita Shah SEBI Registration No. : INM000012573 BATLIVALA & KARANI SECURITIES INDIA PRIVATE LIMITED Ground Floor, City Ice Building, 298 Perin Nariman Street, Fort, Mumbai - 400001, India Telephone: +91 22 4031 7000 Facsimile: +91 22 2263 5020/30 Email: [email protected] Investor Grievance Email: [email protected] Website: www.bksec.com Contact Person Details: Darshan Piyush Trivedi/ Sujeet Gurav SEBI Registration No. : INM000010908 LINK INTIME INDIA PRIVATE LIMITED C-101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West), 400 083, Mumbai, Maharashtra, India Fax: +91 22 4918 6195 E-mail: [email protected] Investor Grievance E-mail: [email protected] Website: www.linkintime.co.in Contact Person: Shanti Gopalkrishnan SEBI Registration No. : INR000004058 BID/OFFER PROGRAMME BID/OFFER OPENS ON: [●] 1 BID/OFFER CLOSES ON: [●] 2 1 Our Company and the Selling Shareholders may, in consultation with the BRLM and CBRLM consider participation by Anchor Investors in accordance with the SEBI ICDR Regulations. The Anchor Investor Bid/Offer Period shall be 1 Working Day prior to the Bid/Offer Opening Date. 2 Our Company and the Selling Shareholders may, in consultation with the BRLM and CBRLM consider closing the Bid/Offer Period for the QIBs 1 Working Day prior to the Bid/Offer Closing Date in accordance with the SEBI ICDR Regulations.

History and Certain Corporate Matters’ on page Registered ...€¦ · ‘History and Certain Corporate Matters’ on page 166. Registered and Corporate Office : 1002, 10 th Floor,

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

  • Draft Red Herring Prospectus

    November 5, 2018

    Please read Section 32 of the Companies Act, 2013

    This Draft Red Herring Prospectus will be updated upon,

    filing the Red Herring Prospectus with ROC

    Book Built Offer

    NEOGEN CHEMICALS LIMITED

    Our Company was incorporated as ‘Neogen Chemicals Private Limited’ on March 7, 1989, at Thane, Maharashtra as a private limited company under the Companies Act, 1956 and

    received a certificate of incorporation from the Registrar of Companies, Mumbai, Maharashtra. Subsequently, pursuant to a special resolution passed by the shareholders of our

    Company on May 2, 1998, our Company was converted to a public limited company and the name of our Company was changed to ‘Neogen Chemicals Limited’, and a fresh

    certificate of incorporation dated July 2, 1998 was issued to our Company by the Registrar of Companies, Mumbai, Maharashtra. For further details, please refer to the chapter

    ‘History and Certain Corporate Matters’ on page 166.

    Registered and Corporate Office: 1002, 10th Floor, Dev Corpora Bldg, Opp. Cadbury Junction, Off Pokhran Road No. 2, Khopat, Thane - 400 601, Maharashtra, India; Tel: +91 22 2549 7300; Fax: +91 22 2549 7399; Corporate Identity Number: U24200MH1989PLC050919;

    Email: [email protected]; Website: www.neogenchem.com;

    Contact Person: Lalit Ashok Karne, Company Secretary and Compliance Officer; Tel: +91 22 2549 7300; Fax: +91 22 2549 7399; Email: [email protected]

    PROMOTERS OF OUR COMPANY: HARIDAS THAKARSHI KANANI AND HARIN HARIDAS KANANI

    INITIAL PUBLIC OFFER OF UP TO [●] EQUITY SHARES OF FACE VALUE OF ₹10 EACH (EQUITY SHARES) OF NEOGEN CHEMICALS LIMITED (OUR COMPANY) FOR CASH AT

    A PRICE OF ₹ [•] PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF ₹ [•] PER EQUITY SHARE) AGGREGATING UP TO ₹ [•] MILLION (OFFER). THE OFFER COMPRISES

    OF A FRESH ISSUE OF UP TO [•] EQUITY SHARES AGGREGATING UP TO ₹ 700.00 MILLION BY OUR COMPANY (FRESH ISSUE) AND AN OFFER FOR SALE OF UP TO 1,699,600

    EQUITY SHARES BY HARIDAS THAKARSHI KANANI (SELLING SHAREHOLDER 1) AND UP TO 1,200,400 EQUITY SHARES BY BEENA HARIDAS KANANI (‘SELLING

    SHAREHOLDER 2’, AND ALONG WITH SELLING SHAREHOLDER 1 COLLECTIVELY REFERRED TO AS THE ‘SELLING SHAREHOLDERS’) AGGREGATING UP TO ₹[•] MILLION

    (OFFER FOR SALE). THE OFFER SHALL CONSTITUTE [•]% OF THE POST-OFFERED PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY.

    THE FACE VALUE OF THE EQUITY SHARES IS ₹10 EACH AND THE OFFER PRICE IS [•] TIMES THE FACE VALUE OF THE EQUITY SHARES. THE PRICE BAND AND THE

    MINIMUM BID LOT WILL BE DECIDED BY OUR COMPANY AND THE SELLING SHAREHOLDERS IN CONSULTATION WITH THE BOOK RUNNING LEAD MANAGER (BRLM)

    AND THE CO-BOOK RUNNING LEAD MANAGER (CBRLM) AND WILL BE ADVERTISED IN ALL EDITIONS OF [●], [●] AND [●] (WHICH ARE WIDELY CIRCULATED DAILY

    ENGLISH, HINDI AND MARATHI NEWSPAPERS, RESPECTIVELY, MARATHI BEING THE REGIONAL LANGUAGE OF MAHARASHTRA, WHERE OUR REGISTERED OFFICE IS

    LOCATED), AT LEAST 5 WORKING DAYS PRIOR TO THE BID/OFFER OPENING DATE AND SHALL BE MADE AVAILABLE TO BSE LIMITED (BSE) AND THE NATIONAL STOCK

    EXCHANGE OF INDIA LIMITED (‘NSE’, AND TOGETHER WITH BSE REFERRED TO AS THE ‘STOCK EXCHANGES’) FOR THE PURPOSES OF UPLOADING ON THEIR

    RESPECTIVE WEBSITES.

    In case of any revisions in the Price Band, the Bid/Offer Period will be extended by at least 3 additional Working Days after such revision of the Price Band, subject to the Bid/Offer Period not exceeding 10

    Working Days. Any revision in the Price Band and the revised Bid/Offer Period, if applicable, will be widely disseminated by notification to the Stock Exchanges, by issuing a press release, and also by

    indicating the change on the website of the BRLM and CBRLM and the terminals of the Syndicate Members and intimation to Self Certified Syndicate Banks (SCSB), Registered Brokers, Collecting Depository

    Participants (CDP) and Registrar to the Issue and Share Transfer Agent (RTA) (and together with the SCSBs, Registered Brokers and CDPs the Registered Intermediary).

    This Offer is being undertaken in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (SCRR) read with Regulation 41 of the Securities and Exchange Board of India (Issue

    of Capital and Disclosure Requirements) Regulations, 2009, as amended (SEBI ICDR Regulations). The Offer is being made through the Book Building Process in accordance with Regulation 26(1) of the

    SEBI ICDR Regulations, wherein not more 50% of the Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (QIBs) (QIB Portion), provided that our Company may,

    in consultation with the BRLM and CBRLM, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations (Anchor Investor Portion),

    out of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price. Further, 5% of the Net

    QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIBs (other

    than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Offer Price. Further, not less than 15% of the Offer shall be available for allocation on a proportionate basis

    to Non-Institutional Investors and not less than 35% of the Offer shall be available for allocation on a proportionate basis to Retail Individual Investors in accordance with the SEBI ICDR Regulations, subject

    to valid Bids being received at or above the Offer Price. All Bidders, other than Anchor Investors, shall participate in the Offer mandatorily through the Applications Supported by Blocked Amount (ASBA)

    process by providing the details of their respective bank accounts in which the corresponding Bid Amount will be blocked by the SCSBs. Anchor Investors are not permitted to participate in the Offer through

    the ASBA process. For details, please refer to the chapter ‘Offer Procedure’ on page 442.

    RISKS IN RELATION TO THE FIRST OFFER

    This being the first public issue of Equity Shares of our Company, there has been no formal market for the Equity Shares. The face value of the Equity Shares is ₹10 each. The Floor Price is [●] times the face

    value of Equity Shares and the Cap Price is [●] times the face value of Equity Shares. The Offer Price (determined and justified by our Company and the Selling Shareholders, in consultation with the BRLM

    and the CBRLM as stated in ‘Basis for Offer Price’ on page 107 ) should not be taken to be indicative of the market price of the Equity Shares after the Equity Shares are listed. No assurance can be given

    regarding an active or sustained trading in the Equity Shares or regarding the price at which the Equity Shares will be traded after listing.

    GENERAL RISKS

    Investments in equity and equity-related securities involve a degree of risk and investors should not invest any funds in this Offer unless they can afford to take the risk of losing their entire investment. Investors

    are advised to read the risk factors carefully before taking an investment decision in this Offer. For taking an investment decision, investors must rely on their own examination of our Company and the Offer,

    including the risks involved. The Equity Shares offered in the Offer have not been recommended or approved by the Securities and Exchange Board of India (SEBI), nor does SEBI guarantee the accuracy or

    adequacy of the contents. Specific attention of the investors is invited to the section ‘Risk Factors’ on page 17.

    COMPANY’S AND SELLING SHAREHOLDERS’ ABSOLUTE RESPONSIBILITY

    Our Company, having made all reasonable inquiries, accepts responsibility for and confirms that this Draft Red Herring Prospectus contains all information with regard to our Company and the Offer, which is

    material in the context of the Offer, that the information contained in this Draft Red Herring Prospectus is true and correct in all material aspects and is not misleading in any material respect, that the opinions

    and intentions expressed herein are honestly held and that there are no other facts, the omission of which makes this Draft Red Herring Prospectus as a whole or any of such information or the expression of any

    such opinions or intentions, misleading in any material respect. Each Selling Shareholder accepts responsibility only for the statements in this Draft Red Herring Prospectus specifically made or confirmed with

    respect to themselves and the Equity Shares offered by them in the Offer for Sale and confirms that such statements are true and correct in all material respects and are not misleading in any material respect.

    LISTING

    The Equity Shares offered in the Offer through the Red Herring Prospectus are proposed to be listed on the BSE and the NSE. In-principle approvals of BSE and NSE for listing the Equity Shares have been

    received pursuant to letter dated [●] and letter dated [●], respectively. For the purposes of the Offer, the Designated Stock Exchange shall be [●]. A signed copy of the Red Herring Prospectus and the Prospectus

    shall be delivered for registration to the RoC in accordance with the Companies Act, 2013. For details of the material contracts and documents available for inspection from the date of the Red Herring Prospectus

    up to the Bid/Offer Closing Date. For details, please refer to the chapter ‘Material Contracts and Documents for Inspection’ on page 515.

    BOOK RUNNING LEAD MANAGER CO-BOOK RUNNING LEAD MANAGER REGISTRAR TO THE OFFER

    INGA ADVISORS PRIVATE LIMITED

    1229, Hubtown Solaris, N.S. Phadke Marg, Opp. Telli

    Galli, Andheri (E) - 400 069,

    Mumbai, Maharashtra, India

    Telephone: +91 22 2681 6003

    Facsimile: +91 22 2681 6020

    Email: [email protected]

    Investor Grievance Email: [email protected] Website: www.ingaadvisors.com

    Contact Person Details: Kavita Shah

    SEBI Registration No.: INM000012573

    BATLIVALA & KARANI SECURITIES INDIA PRIVATE

    LIMITED

    Ground Floor, City Ice Building,

    298 Perin Nariman Street, Fort, Mumbai - 400001, India

    Telephone: +91 22 4031 7000

    Facsimile: +91 22 2263 5020/30

    Email: [email protected]

    Investor Grievance Email: [email protected] Website: www.bksec.com

    Contact Person Details: Darshan Piyush Trivedi/ Sujeet Gurav

    SEBI Registration No.: INM000010908

    LINK INTIME INDIA PRIVATE LIMITED

    C-101, 1st Floor, 247 Park, L.B.S. Marg,

    Vikhroli (West), 400 083,

    Mumbai, Maharashtra, India

    Fax: +91 22 4918 6195

    E-mail: [email protected]

    Investor Grievance E-mail: [email protected]

    Website: www.linkintime.co.in

    Contact Person: Shanti Gopalkrishnan

    SEBI Registration No.: INR000004058

    BID/OFFER PROGRAMME

    BID/OFFER OPENS ON: [●]1 BID/OFFER CLOSES ON: [●]2

    1 Our Company and the Selling Shareholders may, in consultation with the BRLM and CBRLM consider participation by Anchor Investors in accordance with the SEBI ICDR

    Regulations. The Anchor Investor Bid/Offer Period shall be 1 Working Day prior to the Bid/Offer Opening Date. 2 Our Company and the Selling Shareholders may, in consultation with the BRLM and CBRLM consider closing the Bid/Offer Period for the QIBs 1 Working Day prior to the Bid/Offer Closing Date in accordance with the SEBI ICDR Regulations.

    mailto:[email protected]://www.neogenchem.com/mailto:[email protected]:[email protected]

  • 2

    TABLE OF CONTENTS

    SECTION I: GENERAL ........................................................................................................................................... 3

    DEFINITIONS AND ABBREVIATIONS ........................................................................................................... 3

    FORWARD LOOKING STATEMENTS .......................................................................................................... 13

    PRESENTATION OF FINANCIAL, INDUSTRY AND MARKET DATA ................................................... 15

    SECTION II: RISK FACTORS ............................................................................................................................. 17

    SECTION III: INTRODUCTION.......................................................................................................................... 41

    SUMMARY OF INDUSTRY .............................................................................................................................. 41

    SUMMARY OF OUR BUSINESS ...................................................................................................................... 45

    SUMMARY FINANCIAL INFORMATION .................................................................................................... 51

    THE OFFER ......................................................................................................................................................... 64

    GENERAL INFORMATION ............................................................................................................................. 65

    CAPITAL STRUCTURE .................................................................................................................................... 74

    SECTION IV: PARTICULARS OF THE OFFER ............................................................................................. 100

    OBJECTS OF THE OFFER ............................................................................................................................. 100

    BASIS FOR OFFER PRICE ............................................................................................................................. 107

    STATEMENT OF TAX BENEFITS ................................................................................................................ 111

    SECTION V: ABOUT OUR COMPANY ........................................................................................................... 114

    INDUSTRY OVERVIEW ................................................................................................................................. 114

    OUR BUSINESS................................................................................................................................................. 146

    REGULATIONS AND POLICIES ................................................................................................................... 164

    HISTORY AND CERTAIN CORPORATE MATTERS ............................................................................... 166

    OUR MANAGEMENT ...................................................................................................................................... 172

    OUR PROMOTERS AND PROMOTER GROUP ......................................................................................... 189

    GROUP COMPANIES ...................................................................................................................................... 192

    RELATED PARTY TRANSACTIONS ........................................................................................................... 195

    DIVIDEND POLICY ......................................................................................................................................... 196

    SECTION VI: FINANCIAL INFORMATION................................................................................................... 198

    FINANCIAL STATEMENTS ........................................................................................................................... 198

    SUMMARY OF SIGNIFICANT DIFFERENCES BETWEEN INDIAN GAAP AND IND AS ................. 378

    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF

    OPERATION ..................................................................................................................................................... 382

    FINANCIAL INDEBTEDNESS ....................................................................................................................... 401

    OUTSTANDING LITIGATION AND MATERIAL DEVELOPMENTS .................................................... 409

    GOVERNMENT AND OTHER APPROVALS .............................................................................................. 413

    OTHER REGULATORY AND STATUTORY DISCLOSURES ................................................................. 422

    SECTION VIII: OFFER INFORMATION ........................................................................................................ 434

    TERMS OF THE OFFER ................................................................................................................................. 434

    OFFER STRUCTURE ....................................................................................................................................... 439

    OFFER PROCEDURE ...................................................................................................................................... 442

    PART B - GENERAL INFORMATION DOCUMENT FOR INVESTING IN PUBLIC ISSUES ............ 454

    RESTRICTIONS ON FOREIGN OWNERSHIP OF INDIAN SECURITIES ............................................ 488

    SECTION IX: MAIN PROVISIONS OF THE ARTICLES OF ASSOCIATION .......................................... 489

    SECTION X: OTHER INFORMATION ............................................................................................................ 515

    MATERIAL CONTRACTS AND DOCUMENTS FOR INSPECTION ...................................................... 515

    DECLARATION ................................................................................................................................................ 517

  • 3

    SECTION I: GENERAL

    DEFINITIONS AND ABBREVIATIONS

    Unless the context otherwise indicates or implies, the words, expressions or terms used in this Draft Red Herring Prospectus

    shall have the meaning set out below, and references to any statute or regulations, rules or acts or policies shall include

    amendments thereto, from time to time. The words and expressions used in this Draft Red Herring Prospectus but not defined

    herein, shall have, to the extent applicable, the meaning ascribed to such terms under the Companies Act, the SEBI ICDR

    Regulations, the SCRA, the Depositories Act, other apposite statute, or the rules and regulations made thereunder. In case of

    inconsistency between the General Information Document (defined below) and other sections of this Draft Red Herring

    Prospectus, the details mentioned in the other sections of this Draft Red Herring Prospectus shall prevail.

    Notwithstanding the foregoing, terms used in the sections ‘Statement of Tax Benefits’, ‘Industry Overview’, Financial

    Information’, ‘Main Provisions of Articles of Association’, ‘Outstanding Litigation and Material Developments’, ‘Regulations

    and Policies’ and ‘Offer Procedure – Part B’ on pages 111, 114, 198, 489, 409, 164 and 454 respectively, shall have the

    meaning ascribed to such terms in such sections.

    General Company and conventional terms

    Term Description

    Articles/ Articles of Association/

    AoA

    Articles of association of our Company, as amended from time to time

    Audit Committee The committee of the Board of Directors constituted as our Company’s audit

    committee

    Auditor/Statutory Auditor The statutory auditor of our Company viz. JMT & Associates, Chartered Accountants

    Board/Board of Directors Board of Directors of our Company or a duly constituted committee thereof

    “Company’, “our Company”, “the

    Offerer” or “Neogen”

    Neogen Chemicals Limited, a company incorporated under the Companies Act, 1956

    and having its registered office at 1002, 10th Floor, Dev Corpora Building, Opp.

    Cadbury Junction, Off Pokhran Road No. 2, Khopat, Thane - 400 601, Maharashtra,

    India

    Compliance Officer Our company secretary who has been appointed as the compliance officer of our

    Company

    Corporate Office Our corporate office located at 1002, 10th Floor, Dev Corpora Building, Opp. Cadbury

    Junction, Off Pokhran Road No 2, Khopat, Thane – 400 601, Maharashtra, India

    Director(s) The director(s) on the Board of our Company, unless otherwise specified

    Equity Shares Equity shares of our Company of face value of ₹10 each

    9.8% FRCPS 1,070,000 9.8% FRCPS allotted to Karvy Capital Limited

    Group Our Company and Dhara Fine Chem Industries, a partnership firm incorporated under

    the Indian Partnership Act, 1932 and having its office at 23, G.I.D.C Estate, Dabhoi –

    391 110, Dist. Vadodara, Gujarat

    Group Companies Neogen Advance Sciences LLP, a limited liability partnership. For details of our Group

    Companies, please refer to the chapter ‘Group Companies’ on page 192.

    IPO Committee The committee of the Board of Directors constituted in relation to this Offer by the

    Board of Directors

    Key Management Personnel/KMP Those individuals described in the chapter ‘Our Management – Key Management

    Personnel’ on page 172.

    Memorandum/MOA/Memorandum

    of Association

    Memorandum of association of our Company, as amended from time to time

    Nomination and Remuneration

    Committee

    The committee of the Board of Directors constituted as our Company’s nomination

    and remuneration committee

    10% OCPS 10% cumulative optionally convertible preference shares

    Promoters The promoters of our Company viz. Haridas Thakarshi Kanani and Harin Haridas

    Kanani

    Promoter Group The individuals and entities constituting our promoter group pursuant to Regulation

    2(1)(zb) of the SEBI ICDR Regulations

    Registered Office The registered office of our Company, situated at 1002, 10th Floor, Dev Corpora

    Building, Opp. Cadbury Junction, Off Pokhran Road No. 2, Khopat, Thane 400 601,

    Maharashtra, India

    Registrar of Companies/RoC Registrar of Companies, Mumbai, Maharashtra

    Restated Consolidated Financial

    Statements

    Proforma Ind AS Restated Consolidated Financial Information as at and for the 6

    month period ended September 30, 2018, March 31, 2018, March 31, 2017, March 31,

    2016, March 31, 2015, March 31, 2014 and included in the chapter ‘Financial

  • 4

    Term Description

    Statements’ on page 198.

    Restated Financial Statements Collectively, the Restated Standalone Financial Statements and Restated Consolidated

    Financial Statements

    Restated Standalone Financial

    Statements

    Proforma Ind AS Restated Standalone Financial Information as at and for the 6 month

    period ended September 30, 2018, March 31, 2018, March 31, 2017, March 31, 2016,

    March 31, 2015, March 31, 2014 and included in the chapter ‘Financial Statements’

    on page 198 and included in the chapter ‘Financial Statements’ on page 198.

    Selling Shareholder 1 Haridas Thakarshi Kanani

    Selling Shareholder 2 Beena Haridas Kanani

    Selling Shareholders Collectively, Selling Shareholder 1 and Selling Shareholder 2

    Shareholders Shareholders of our Company, from time to time

    Stakeholders’ Relationship

    Committee

    The committee of the Board of Directors constituted as our Company’s Stakeholders’

    Relationship Committee

    Revenue from Operations Total operating revenue adjusted for excise and cash discount.

    “We”, “us” or “our” Unless the content otherwise indicates or implies, refers to our Company on a

    consolidated basis together with the partnership firm, Dhara Fine Chem Industries

    Offer Related Terms

    Term Description

    Abridged Prospectus Abridged prospectus prepared in accordance with Regulation 58 of SEBI ICDR Regulations

    and appended to the Bid Cum Application Form

    Acknowledgement Slip The slip or document issued by the Designated Intermediary to a Bidder as proof of

    registration of the Bid Cum Application Form

    Allot/Allotment/Allotted Unless the context otherwise requires, the allotment of the Equity Shares pursuant to the Fresh

    Issue and transfer of the Offered Shares pursuant to the Offer for Sale to the successful Bidders

    Allotment Advice Note or advice or intimation of Allotment sent to the successful Bidders who have been or are

    to be Allotted the Equity Shares after the Basis of Allotment has been approved by the

    Designated Stock Exchange

    Allottee A successful Bidder to whom the Equity Shares are Allotted

    Anchor Investor(s) A Qualified Institutional Buyer, applying under the Anchor Investor Portion, with a minimum

    Bid of ₹100 million, in accordance with the SEBI ICDR Regulations

    Anchor Investor Allocation

    Price

    The price at which Equity Shares will be allocated to the Anchor Investors in terms of the Red

    Herring Prospectus and the Prospectus, which will be decided by our Company and Selling

    Shareholders in consultation with the BRLM and the CBRLM on the Anchor Investor

    Bid/Offer Period

    Anchor Investor Application

    Form

    The form used by an Anchor Investor to make a Bid in the Anchor Investor Portion and which

    will be considered as an application for Allotment in terms of the Red Herring Prospectus and

    the Prospectus

    Anchor Investor Bid/Offer

    Period

    The day, one Working Day prior to the Bid/Offer Opening Date, on which Bids by Anchor

    Investors shall be submitted, prior to, and after which, the BRLM and CBRLM will not accept

    any bids from Anchor Investors and allocation to Anchor Investors shall be completed

    Anchor Investor Offer Price Final price at which the Equity Shares will be issued and Allotted to Anchor Investors in terms

    of the Red Herring Prospectus and the Prospectus, which price will be equal to or higher than

    the Offer Price, but not higher than the Cap Price. The Anchor Investor Offer Price will be

    decided by our Company and the Selling Shareholders in consultation with the BRLM and

    the CBRLM.

    Anchor Investor Pay-in Date In case of the Anchor Investor Offer Price being higher than the Anchor Investor Allocation

    Price, the date as mentioned in the CAN but not later than 2 Working Days after the Bid/

    Offer Closing Date

    Anchor Investor Portion Up to 60% of the QIB Portion, consisting up to [●] Equity Shares, which may be allocated by

    our Company in consultation with the BRLM and CBRLM, to Anchor Investors on a

    discretionary basis. One-third of the Anchor Investor Portion shall be reserved for domestic

    Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above

    the Anchor Investor Allocation Price

    Application Supported by

    Blocked Amount/ASBA

    An application, whether physical or electronic, used by ASBA Bidders, to make a Bid

    authorizing a SCSB to block the Bid Amount in the ASBA Account

    ASBA Account A bank account maintained with an SCSB and specified in the ASBA Form submitted by

    ASBA Bidders for blocking the Bid Amount mentioned in the ASBA Form

    ASBA Bid A Bid made by an ASBA Bidder including all revisions and modifications thereto as permitted

    under the SEBI ICDR Regulations

  • 5

    Term Description

    ASBA Bidder(s) All Bidders except Anchor Investors

    ASBA Form An application form, whether physical or electronic, used by ASBA Bidders, which will be

    considered as the application for Allotment in terms of the Red Herring Prospectus and the

    Prospectus

    Basis of Allotment Basis on which the Equity Shares will be Allotted to successful Bidders under the Offer and

    which is described in the chapter ‘Offer Procedure- Allotment Procedure and Basis of

    Allotment’ on page 477.

    Bid(s) An indication to make an offer during the Bid/Offer Period by a Bidder other than an Anchor

    Investor pursuant to submission of the ASBA Form, or during the Anchor Investor Bid/Offer

    Period by the Anchor Investors pursuant to submission of the Anchor Investor Application

    Form, to subscribe to the Equity Shares at a price within the Price Band, including all revisions

    and modifications thereto as permitted under the SEBI ICDR Regulations in terms of the Red

    Herring Prospectus and Bid cum Application Form. The term ‘Bidding’ shall be construed

    accordingly.

    Bid Amount The highest value of optional Bids indicated in the Bid cum Application Form and payable

    by the Bidder/blocked in the ASBA Account on submission of a bid in the Offer

    Bid cum Application Form The Anchor Investor Application Form or the ASBA Form, as the context requires

    Bid/Offer Closing Date Except in relation to any Bids received from the Anchor Investors, the date after which the

    Designated Intermediaries will not accept any Bids, which shall be notified in all editions of

    the English national newspaper [●], all editions of the Hindi national newspaper [●] and

    Mumbai edition of the Marathi newspaper [●] (Marathi being the regional language of

    Maharashtra where our Registered Office is located), each with wide circulation

    Bid/Offer Opening Date Except in relation to any Bids received from the Anchor Investors, the date on which the

    Designated Intermediaries shall start accepting ASBA Bids for the Offer, which shall be

    notified in all editions of the English national newspaper [●],all editions of the Hindi national

    newspaper [●] and Mumbai edition of the Marathi newspaper [●] (Marathi being the regional

    language of Maharashtra where our Registered Office is located), each with wide circulation

    Bid/Offer Period Except in relation to Anchor Investors, the period between the Bid/Offer Opening Date and the

    Bid/Offer Closing Date, inclusive of both days, during which prospective investors can submit

    their Bids, including any revisions thereof.

    Our Company and Selling Shareholders in consultation with the BRLM and the CBRLM, may

    consider closing the Bid/Offer Period for QIBs, 1 Working Day prior to the Bid/Offer Closing

    Date, in accordance with the SEBI ICDR Regulations, which shall also be notified in an

    advertisement in the same newspapers in which the Bid/Offer Opening Date was published, as

    required under the SEBI ICDR Regulations, which shall also be notified in an advertisement

    in same newspapers in which the Bid/Offer Opening Date was published, as required under the

    SEBI ICDR Regulations.

    Bid Lot [●] Equity Shares

    Bidder Any prospective investor who makes a Bid pursuant to the terms of the Red Herring

    Prospectus and the Bid cum Application Form and unless otherwise stated or implied,

    includes an Anchor Investor

    Bidding Centres Centres at which the Designated Intermediaries shall accept the ASBA Forms i.e. Designated

    SCSB Branch for SCSBs, Specified Locations for Syndicate, Broker Centres for Registered

    Brokers, Designated RTA Locations for RTAs and Designated CDP Locations for CDPs

    Book Building Process The book building process, as provided in Schedule XI of the SEBI ICDR Regulations, in

    terms of which the Offer is being made

    Broker Centres Broker centres notified by the Stock Exchanges, where Bidders can submit the ASBA Forms

    to a Registered Broker. The details of such Broker Centres, along with the name, bidding and

    contact details of the Registered Brokers are available on the websites of the respective Stock

    Exchanges (www.bseindia.com and www.nseindia.com)

    BRLMs/Book Running Lead

    Manager

    The book running lead managers to the Offer, being Inga Advisors Private Limited

    CAN/Confirmation of

    Allocation Note

    Notice or intimation of allocation of the Equity Shares sent to Anchor Investors, who have

    been allocated the Equity Shares, after the Anchor Investor Bid/Offer Period

    Cap Price The higher end of the Price Band, subject to any revisions thereto, above which the Offer

    Price and the Anchor Investor Offer Price will not be finalised and above which no Bids will

    be accepted

    CBRLM/Co-Book Running

    Lead Manager

    The co-book running lead manager being Batlivala & Karani Securities India Private Limited

  • 6

    Term Description

    Collecting Depository

    Participant(s) or CDP(s)

    A depository participant as defined under the Depositories Act, 1996, registered with SEBI and

    who is eligible to procure Bids at the Designated CDP Locations in terms of circular No.

    GR/CFD/POLICYCELL/11/2015 dated November 10, 2015 issued by SEBI

    Controlling Branches Such branches of SCSBs which coordinate Bids under the Offer with the BRLM and the

    CBRLM, the Registrar and the Stock Exchanges, a list of which is available on the website of

    SEBI at http://www/sebi.gov.in

    Cut-off Price The Offer Price, finalised by our Company and the Selling Shareholders in consultation with

    BRLM and the CBRLM, which shall be any price within the Price Band. Only Retail

    Individual Bidders are entitled to Bid at the Cut-off Price. QIBs and Non-Institutional Bidders

    are not entitled to Bid at the Cut-off Price

    Demographic Details Details of the Bidders including the Bidder’s address, name of the Bidder’s father/ husband,

    investor status, occupation and bank account details

    Designated Date The date on which the funds are transferred by the Escrow Collection Bank(s) from the

    Escrow Account(s) or the instructions are given to the SCSBs to unblock the ASBA Accounts

    and transfer the amounts blocked by SCSBs as the case may be, to the Public Offer Account

    or the Refund Account, as appropriate in terms of the Red Herring Prospectus and the

    Prospectus, and the aforesaid transfer and instructions shall be issued only after finalisation

    of the Basis of Allotment in consultation with the Designated Stock Exchange

    Designated Intermediaries Syndicate, sub-syndicate, SCSBs, Registered Brokers, the CDPs and RTAs, who are

    authorised to collect ASBA Forms from the Bidders, in relation to the Offer

    Designated CDP Locations Such locations of the CDPs where ASBA Bidders can submit the ASBA Forms. The details

    of such Designated CDP Locations, along with names and contact details of the Collecting

    Depository Participants eligible to accept ASBA Forms are available on the respective

    websites of the Stock Exchanges www.bseindia.com and www.nseindia.com

    Designated RTA Locations Such locations of the RTAs where ASBA Bidders can submit the ASBA Forms to RTAs. The

    details of such Designated RTA Locations, along with names and contact details of the RTAs

    eligible to accept ASBA Forms are available on the respective websites of the Stock Exchanges

    www.bseindia.com and www.nseindia.com

    Designated SCSB Branches Such branches of the SCSBs which shall collect the ASBA Forms submitted by ASBA

    Bidders, a list of which is available on the website of SEBI at www.sebi.gov.in/ or such other

    website as may be prescribed by SEBI from time to time

    Designated Stock Exchange [●]

    Draft Red Herring

    Prospectus or DRHP

    This Draft Red Herring Prospectus dated November 5, 2018 issued in accordance with the

    SEBI ICDR Regulations including any addenda or corrigenda thereto.

    Eligible NRI(s) NRIs from jurisdictions outside India where it is not unlawful to make an offer or invitation

    under the Offer and in relation to whom the ASBA Form and the Red Herring Prospectus will

    constitute an invitation to subscribe to or purchase the Equity Shares

    Escrow Account(s) Account(s) opened for the Offer with the Escrow Collection Bank(s) and in whose favour the

    Anchor Investors will transfer money through direct credit/ NEFT/RTGS in respect of the Bid

    Amount when submitting a Bid

    Escrow Agent [●]

    Escrow Agreement Agreement to be entered into by our Company, Selling Shareholders the Registrar to the Offer,

    the BRLM, the CBRLM, the Escrow Collection Bank(s), the Refund Banker and the Public

    Offer Bank(s) for collection of the Bid Amounts from the Anchor Investors, transfer of funds

    from the Escrow Account to the Public Offer Account and where applicable, refunds of the

    amounts collected from the Bidders, on the terms and conditions thereof

    Escrow Collection Bank(s) Banks which are clearing members and registered with SEBI as bankers to an issue and with

    whom Escrow Account(s) will be opened

    Equity Listing Agreements The listing agreements to be entered into by our Company with the Stock Exchanges in

    relation to our Equity Shares

    First Bidder The Bidder whose name appears first in the Bid cum Application Form in case of a joint Bid

    and whose name shall also appear as the first holder of the beneficiary account held in joint

    names or any revisions thereof

    Floor Price The lower end of the Price Band, subject to any revision thereto, at or above which the Offer

    Price and the and Anchor Investor Offer Price will be finalised and below which no Bids will

    be accepted

    Fresh Issue The issue of up to [●] Equity Shares aggregating up to ₹ 700.00 million proposed to be issued

    by our Company as part of the Offer

    General Information

    Document/GID

    The General Information Document prepared and issued in accordance with the circular

    (CIR/CFD/DIL/12/2013) dated October 23, 2013 notified by SEBI and updated pursuant to

    the circulars (CIR/CFD/POLICYCELL/III/2015) dated November 10, 2015 and

    http://www.nseindia.com/http://www.nseindia.com/

  • 7

    Term Description

    (SEBI/HO/CFD/DIL/CIR/P/2016/26) dated January 21, 2016, suitably modified and included

    in the chapter ‘Offer Procedure’ on page 442.

    Mutual Funds Mutual funds registered with SEBI under the Securities and Exchange Board of India (Mutual

    Funds) Regulations, 1996

    Mutual Fund Portion 5% of the QIB Portion (excluding the Anchor Investor Portion), or [●] Equity Shares which

    shall be available for allocation to Mutual Funds only

    Net Proceeds Proceeds of the Offer, less Offer related expenses. For further information about the Offer

    related expenses, please refer to the chapter ‘Objects of the Offer’ on page 100

    Net QIB Portion The portion of the QIB Portion less the number of Equity Shares allocated to the Anchor

    Investors

    Non-Institutional Bidders All Bidders that are not QIBs or Retail Individual Bidders and who have Bid for the Equity

    Shares for an amount more than ₹ 200,000 (but not including NRIs other than Eligible NRIs)

    Non-Institutional Portion The portion of the Offer being not less than 15% of the Offer consisting of [●] Equity Shares

    which shall be available for allocation on a proportionate basis to Non-Institutional Bidders,

    subject to valid Bids being received at or above the Offer Price

    Offer The initial public offer of up to [●] Equity Shares of face value of ₹ 10 each for cash at a price

    of ₹ [●] each, aggregating up to ₹ [●] million, comprising: (i) the Fresh Issue of up to [●]

    Equity Shares aggregating up to ₹ 700.00 million; and (ii) Offer for Sale of up to 2,900,000

    Equity Shares aggregating up to ₹ [●] million by the Selling Shareholders.

    Offer Agreement The agreement dated November 5, 2018 between our Company, Selling Shareholders and the

    BRLM and the CBRLM, pursuant to which certain arrangements are agreed to in relation to

    the Offer

    Offer for Sale The offer for sale of Equity Shares by the Selling Shareholders, aggregating up to 2,900,000

    Equity Shares comprising an offer for sale by Haridas Thakarshi Kanani of up to 1,699,600

    Equity Shares and offer for sale by Beena Haridas Kanani of up to 1,200,400 at the Offer

    Price in terms of the Red Herring Prospectus.

    Offer Proceeds The proceeds of the Offer which shall be available to the Company. For further information

    about use of the Offer Proceeds, please refer to the chapter ‘Objects of the Offer’ on page 100

    Offer Price The final price at which the Equity Shares will be Allotted to Bidders other than Anchor

    Investors. Equity Shares will be Allotted to Anchor Investors at the Anchor Investor Offer

    Price in terms of the Red Herring Prospectus. The Offer Price will be decided by our Company

    and the Selling Shareholders in consultation with the BRLM and the CBRLM, on the Pricing

    Date. Unless otherwise stated or the context otherwise implies, the term Offer Price refers to

    the Offer Price applicable to investors other than Anchor Investors

    Offered Shares Up to 2,900,000 Equity Shares aggregating up to ₹ [●] million offered by the Selling

    Shareholders in the Offer

    Price Band Price Band of a minimum price of ₹ [●] per Equity Share (Floor Price) and the maximum

    price of ₹ [●] per Equity Share (Cap Price), including any revisions thereof.

    The Price Band will be decided by our Company and the Selling Shareholders in consultation

    with the BRLM and the CBRLM and will be advertised, at least 5 Working Days prior to the

    Bid/Offer Opening Date, in [●] editions of the English national newspaper [●], [●] editions

    of the Hindi national newspaper [●] and [●] editions of the Marathi newspaper [●] (Marathi

    being the regional language of Maharashtra where our registered office is located), each with

    wide circulation and shall be made available to the Stock Exchanges for the purpose of

    uploading on their respective websites.

    Pricing Date The date on which our Company and the Selling Shareholders in consultation with BRLM

    and the CBRLM will finalise the Offer Price

    Prospectus The Prospectus to be filed with the RoC in accordance with section 26 of the Companies Act,

    2013 and the SEBI ICDR Regulations containing, inter alia, the Offer Price that is determined

    through the Book Building Process, the size of the Offer and certain other information,

    including any addenda or corrigenda thereto

    Public Offer Account Account opened with the Public Offer Bank(s) to receive monies from the Escrow Account(s)

    and to which the funds shall be transferred by the SCSBs from the ASBA Accounts of the

    successful Allottees, on or after the Designated Date

    Public Offer Bank(s) Bank(s) with whom the Public Offer Account for collection of bidding amount from Escrow

    Account(s) and ASBA Accounts of the successful Allottees will be opened

    QIB Portion The portion of the Offer (including the Anchor Investor Portion) being not more than 50% of

    the Offer, which shall be allocated on a proportionate basis to QIBs, including the Anchor

    Investor subject to valid Bids being received at or above the Offer Price

    Qualified Institutional Qualified institutional buyers as defined under Regulation 2(1)(zd) of the SEBI ICDR

  • 8

    Term Description

    Buyers/QIBs Regulations

    Red Herring Prospectus/RHP The Red Herring Prospectus to be issued in accordance with section 32 of the Companies Act,

    2013 and the provisions of the SEBI ICDR Regulations, which will not have complete

    particulars of the price at which the Equity Shares will be offered and the size of the Offer,

    and includes any addenda and corrigenda thereto. The Red Herring Prospectus will be filed

    with the RoC at least 3 Working Days before the Bid/Offer Opening Date and will become

    the Prospectus upon filing with the RoC after the Pricing Date

    Refund Account(s) The account opened with the Refund Banker, from which refunds, if any, of the whole or part

    of the Bid Amount to Anchor Investors shall be made

    Refund Banker [●]

    Refunds through electronic

    transfer of funds

    Refunds through NACH, Direct Credit, RTGS or NEFT, as applicable

    Registered Brokers Stock Brokers registered with SEBI under the Securities and Exchange Board of India (Stock

    Brokers and Sub Brokers) Regulations, 1992 and the Stock Exchanges having nationwide

    terminals, other than the members of the Syndicate and having terminals at any of the Broker

    Centres and eligible to procure Bids in terms of Circular No. CIR/CFD/14/2012 dated October

    4, 2012 issued by SEBI

    Registrar Agreement The agreement dated November 3, 2018 between our Company, Selling Shareholders and the

    Registrar to the Offer in relation to the responsibilities and obligations of the Registrar to the

    Offer pertaining to the Offer

    Registrar and Share Transfer

    Agents/RTAs

    Registrar and share transfer agents registered with SEBI and eligible to procure Bids at the

    Designated RTA Locations in terms of circular No. CIR/CFD/POLICYCELL/11/2015 dated

    November 10, 2015 issued by SEBI

    Registrar to the

    Offer/Registrar

    Registrar to the Offer, in this case being Link Intime India Private Limited

    Retail Individual Bidder(s) Individual Bidders who have Bid for the Equity Shares for an amount not more than ₹ 200,000

    in any of the bidding options in the Offer (including HUFs applying through their Karta and

    Eligible NRIs)

    Retail Portion The portion of the Offer being not less than 35% of the Offer consisting of [●] Equity Shares

    which shall be available for allocation to Retail Individual Bidder(s) subject to valid Bids

    being received at or above the Offer Price

    Revision Form Form used by the Retail Individual Bidders to modify the quantity of the Equity Shares or the

    Bid Amount in any of their ASBA Forms or any previous revision form(s) before closure of

    the Offer. Kindly note that QIBs and Non-Institutional Bidders are not allowed to withdraw

    or lower their Bid (in terms of quality of Equity Shares or the Bid Amount) at any stage, once

    submitted

    Self-Certified Syndicate

    Banks or SCSBs

    The banks registered with SEBI, offering services in relation to ASBA, a list of which is

    available on the website of SEBI at http://www.sebi.gov.in/sebiweb /home

    /list/5/33/0/0/Recognised-Intermediaries or at such other website as may be prescribed by

    SEBI from, time to time

    Specified Locations Bidding centres where the Syndicate shall accept ASBA Forms from Bidders

    Stock Exchanges BSE and NSE

    Syndicate Agreement The agreement to be entered into amongst the BRLM. The CBRLM, the Syndicate Members,

    the Registrar to the Offer, the Selling Shareholders and our Company in relation to the

    collection of Bid cum Application Forms by the Syndicate

    Syndicate Members Intermediaries registered with the SEBI who are permitted to carry out activities as an

    underwriter, namely, [●]

    Syndicate/members of the

    Syndicate

    BRLM, CBRLM and the Syndicate Members

    TRS/Transaction

    Registration Slip

    The slip or document issued by the Syndicate, or the SCSB (only on demand), as the case may

    be, to the Bidder as proof of registration of the Bid

    Underwriters BRLM, CBRLM and the Syndicate Members

    Underwriting Agreement The agreement amongst the Underwriters, the Selling Shareholders and, our Company to be

    entered into on or after the Pricing Date

    Working Days All days other than second and fourth Saturdays of the month, Sundays or public holidays, on

    which commercial banks in Mumbai are open for business; provided however ‘Working Day’,

    with reference to (a) announcement of Price Band; and (b) Bid/Offer Period, shall mean all

    days, excluding Saturdays, Sundays and public holidays, on which commercial banks in

    Mumbai are open for business; and (c) the time period between the Bid/Offer Closing Date

    and the listing of the Equity Shares on the Stock Exchanges, shall mean all trading days of

    Stock Exchanges, excluding Sundays and bank holidays, as per the SEBI Circular

    http://www.sebi.gov.in/sebiweb

  • 9

    Term Description

    SEBI/HO/CFD/DIL/CIR/P/2016/26 dated January 21, 2016

    Business / Industry Related Terms

    Term Description

    APAC region Asia Pacific Region

    API Active pharmaceutical ingredient

    Bromine A chemical element with symbol ‘Br’

    Brominating agent A chemical compound capable of introducing bromine into a molecule

    Bromination A chemical reaction by which bromine is introduced to a compound or material

    Brominated compound A chemical which has been treated or introduced with Bromine by way of Bromination

    Bromine source A compound or chemical which is a primary source of Bromine

    CPhI Convention on Pharmaceutical Ingredients

    Grignard reagent A chemical formed by reaction of magnesium with an organic halide

    Halogenation A chemical reaction by which a halogenic element such as Bromine is added to a

    compound

    HVAC Heating ventilation and air-conditioning industry.

    Inorganic chemicals Chemicals with an ionic bond

    Ionic bond A chemical bond between a non-metal and a metal ion

    ISO Storage Tanks Storage tanks built as per standards prescribed by International Organisation for

    Standardisation.

    Lithium A chemical element with symbol ‘Li’

    Lithium compounds The specialty inorganic lithium-based chemical products of our Company

    Lithium Source A compound or chemical which is a primary source of Lithium

    Mahape Facility Our manufacturing facility located in Mahape, Navi Mumbai, Maharashtra

    Organic chemicals Chemicals with a covalent bond.

    Proposed Dahej Facility Planned additional facility in Dahej SEZ, Dahej Gujarat

    Proposed Vadodara Facility Planned additional facility at Karakhadi, Vadodara, Gujarat

    Specialty Chemicals Those chemicals that impart different properties to a variety of products (i.e. the effect

    that specialty chemicals have varies based on the product) and have a high degree of value

    addition.

    Vadodara Facility Our manufacturing facility located in Karakhadi Vadodara, Gujarat.

    VAM Vapour absorption machines

    Abbreviations

    Term Description

    A/c Account

    AGM Annual General Meeting

    AIF Alternative Investment Fund as defined in and registered with SEBI under the

    Securities and Exchange Board of India (Alternative Investments Funds) Regulations,

    2012

    AS/Accounting Standards Accounting Standards issued by the ICAI

    AY Assessment Year

    BSE BSE Limited

    Banking Regulation Act The Banking Regulation Act, 1949, as amended

    CAGR Compounded Annual Growth Rate

    Calendar Year Unless the context requires, shall refer to the 12-month period ending December 31, of

    the year

    Category II foreign portfolio

    investor(s)/ Category II FPIs

    FPIs who are registered as ‘Category II foreign portfolio investors’ under the SEBI FPI

    Regulations

    Category III foreign portfolio

    investor(s)/ Category III FPIs

    FPIs who are registered as ‘Category III foreign portfolio investors’ under the SEBI

    FPI Regulations

    CDSL Central Depository Services (India) Limited

    CEO Chief Executive Officer

    CENVAT Central Value Added Tax

    CESTAT Customs, Excise and Service Tax Appellate Tribunal

  • 10

    CFO Chief Financial Officer

    CIN Corporate identity number

    CIT Commissioner of Income Tax

    Client ID Client identification number of the Bidder’s beneficiary account

    Companies Act/Act Companies Act, 1956 and/or the Companies Act, 2013, as applicable

    Companies Act, 1956 Companies Act, 1956, as amended (without reference to the provisions thereof that

    have ceased to have effect upon the notification of the Notified Sections)

    Companies Act, 2013 The Companies Act, 2013, to the extent in force pursuant to the notification of the

    Notified Sections

    CRISIL CRISIL Limited

    CRISIL Report Report titled ‘Assessment of the specialty chemicals industry in India’ issued by

    CRISIL Research in August 2018

    CRISIL Research A division of CRISIL

    CSO Central Statistics Office

    CSR Corporate social responsibility

    CST Central Sales Tax

    Depositories NSDL and CDSL

    Depositories Act Depositories Act, 1996

    DIN Director Identification Number

    DIPP Department of Industrial Policy and Promotion

    DP/ Depository Participant A depository participant as defined under the Depositories Act

    DP ID Depository participant’s identification

    ECS Electronic Clearing Service

    EGM Extraordinary General Meeting

    Electricity Act Electricity Act, 2003

    EPS Earnings Per Share i.e. profit after tax for a Fiscal divided by the weighted average

    outstanding number of equity shares at the end of that Fiscal

    ESOP Employee Stock Option Plan

    FCNR Foreign currency non-resident

    FDI Foreign Direct Investment

    FEMA Foreign Exchange Management Act, 1999 read with rules and regulations thereunder

    FEMA Regulations Foreign Exchange Management (Transfer or Issue of Security by a Person Resident

    Outside India) Regulations, 2017, as amended

    FIFO First in first out

    FII(s) Foreign Institutional Investors as defined under the SEBI FPI Regulations

    FPI(s) Foreign Portfolio Investors as defined under the SEBI FPI Regulations

    Financial Year / Fiscal / FY Period of twelve months ended March 31 of that particular year

    FVCI Foreign Venture Capital Investors as defined and registered with SEBI under the SEBI

    FVCI Regulations

    GDP Gross Domestic Product

    GIR General index register

    GoI/Government Government of India

    GST Goods and Services Tax

    HNI High Networth Individual

    HUF Hindu Undivided Family

    ICSI Institute of Company Secretaries of India

    IFRS International Financial Reporting Standards issued by International Accounting

    Standards Board

    IMF International Monetary Fund

    Indian GAAP Generally Accepted Accounting Principles in India

    Ind AS Indian Accounting Standards prescribed under section 133 of the Companies Act,

    2013, as notified under the Companies (Indian Accounting Standard) Rules, 2015

    IPO Initial public offering

  • 11

    ISIN International Securities Identification Number

    IT Information Technology

    I.T. Act The Income Tax Act, 1961

    ITAT Income Tax Appellate Tribunal

    KL Kilo litre

    LC Letter of Credit

    LLP Act Limited Liability Partnership Act, 2008

    MCLR Marginal Cost of Funds based Lending Rate

    MICR Magnetic ink character recognition

    MIDC Maharashtra Industrial Development Corporation

    Mn / mn Million

    MOEF Ministry of Environment and Forests

    MoU Memorandum of Understanding

    N.A. Not applicable

    National Investment Fund National Investment Fund set up by resolution F. No. 2/3/2005-DD-II dated November

    23, 2005 of the GoI, published in the Gazette of India

    NAV Net Asset Value being paid up equity share capital plus free reserves (excluding

    reserves created out of revaluation) less deferred expenditure not written off (including

    miscellaneous expenses not written off) and debit balance of profit and loss account,

    divided by number of issued equity shares

    NCT National Capital Territory

    NECS National Electronic Clearing Service

    NEFT National Electronic Fund Transfer

    NGO Non-Governmental Organisation

    Notified Sections The sections of the Companies Act, 2013 that have been notified as having come into

    effect prior to the date of this Draft Red Herring Prospectus

    NOC No Objection Certificate

    NR/Non-Resident A person resident outside India, as defined under the FEMA and includes an NRI, FIIs

    registered with SEBI and FVCIs registered with SEBI

    NRE Account Non Resident External Account

    NRI A person resident outside India, who is a citizen of India or a person of Indian origin,

    and shall have the meaning ascribed to such term in the Foreign Exchange

    Management (Deposit) Regulations, 2000

    NRO Account Non Resident Ordinary Account

    NSDL National Securities Depository Limited

    NSE National Stock Exchange of India Limited

    OCB / Overseas Corporate

    Body

    A company, partnership, society or other corporate body owned directly or indirectly

    to the extent of at least 60% by NRIs including overseas trusts, in which not less than

    60% of beneficial interest is irrevocably held by NRIs directly or indirectly and which

    was in existence on October 3, 2003 and immediately before such date had taken

    benefits under the general permission granted to OCBs under FEMA

    OFS Offer for Sale

    p.a. Per annum

    PBDITA Profit Before Interest, Taxes, Depreciation and Amortization

    P&L Profit and loss

    P/E Ratio Price/earnings Ratio

    PAN Permanent Account Number allotted under the Income Tax Act, 1961

    PAT Profit after tax

    PIO Persons of Indian Origin

    QE Quarter ended

    QIB Qualified Institutional Buyer

    RBI The Reserve Bank of India

    Registration Act Registration Act, 1908

  • 12

    Regulation S Regulations S under the Securities Act

    RONW Return on Net Worth

    Rupees/Rs./₹/INR Indian Rupees

    RTGS Real Time Gross Settlement

    SBI State Bank of India

    SCRA Securities Contracts (Regulation) Act, 1956

    SCRR Securities Contracts (Regulation) Rules, 1957

    SEBI The Securities and Exchange Board of India constituted under the SEBI Act, 1992

    SEBI Act Securities and Exchange Board of India Act, 1992

    SEBI AIF Regulations Securities and Exchange Board of India (Alternative Investments Funds) Regulations,

    2012

    SEBI FII Regulations Securities and Exchange Board of India (Foreign Institutional Investors) Regulations,

    1995

    SEBI FPI Regulations Securities and Exchange Board of India (Foreign Portfolio Investors) Regulations,

    2014

    SEBI FVCI Regulations Securities and Exchange Board of India (Foreign Venture Capital Investor)

    Regulations, 2000

    SEBI ICDR Regulations Securities and Exchange Board of India (Issue of Capital and Disclosure

    Requirements) Regulations, 2009

    SEBI Listing Regulations Securities and Exchange Board of India (Listing Obligations and Disclosure

    Requirements) Regulations, 2015

    SEBI Takeover Regulations Securities and Exchange Board of India (Substantial Acquisition of Shares and

    Takeovers) Regulations, 2011

    SEBI VCF Regulations Securities and Exchange Board of India (Venture Capital Funds) Regulations, 1996 as

    repealed pursuant to the SEBI AIF Regulations

    Securities Act United States Securities Act of 1933

    SICA Sick Industrial Companies (Special Provisions) Act, 1985

    Sq. Ft./sq. ft. Square feet

    State Government The Government of a state in India

    Sec. Section

    SEZ Special Economic Zone

    Stamp Act The Indian Stamp Act, 1899

    Stock Exchange(s) BSE and/or NSE as the context may refer to

    TAN Tax Deduction Account Number

    TDS Tax Deducted at Source

    T.P. Act Transfer of Property Act, 1882

    TR Ton of refrigeration

    UIN Unique Identification Number

    US / USA / United States United States of America

    US GAAP Generally Accepted Accounting Principles in the United States of America

    USD / US$ United States Dollars

    VAT Value added tax

    VCFs Venture capital funds as defined in and registered with SEBI under the SEBI VCF

    Regulations or the SEBI AIF Regulations, as the case may be

    WC Working capital

    WEO World economic outlook

    WPI Wholesale Price Index

    Notwithstanding the foregoing, terms in the chapters ‘Industry Overview’, ‘Statement of Tax Benefits’, ‘Financial Statements’,

    ‘Offer Procedure – Part B - General Information Document for Investing in Public Issues’ and ‘Main Provisions of Articles

    of Association’ on pages 114, 111, 198, 442 and 489, respectively, shall have the meaning given to such terms in such sections.

  • 13

    FORWARD LOOKING STATEMENTS

    Certain statements in this Draft Red Herring Prospectus are not historical facts but are ‘forward-looking’ in nature. Forward-

    looking statements include statements concerning our Company’s plans, objectives, goals, strategies, future events, future

    revenues or financial performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, our

    Company’s competitive strengths and weaknesses, our Company’s business strategy and the trends our Company anticipates

    in the industries and the political and legal environment, and geographical locations, in which our Company operates, and other

    information that is not historical information, and is based on the current views of our Company’s management.

    Words such as “believe”, “anticipate”, “estimate”, “seek”, “expect”, “continue”, “intend”, “predict”, “project”, “should”,

    “goal”, “future”, “could”, “may”, “will”, “would”, “targets”, “aims”, “is likely to”, “plan” and similar expressions, or variations

    of such expressions, are intended to identify forward-looking statements but are not the exclusive means of identifying such

    statements.

    All forward looking statements are subject to risks, uncertainties and assumptions about our Company that could cause actual

    results to differ materially from those contemplated by the relevant forward-looking statement and there can be no assurance

    that any of these will prove to be correct.

    These risks, uncertainties and other factors include, among other things, those listed under the section ‘Risk Factors’ on page

    17, as well as those included elsewhere in this Draft Red Herring Prospectus. Prospective Investors should be aware that a

    number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates

    and intentions expressed in such forward-looking statements. These factors include, but are not limited to regulatory changes

    pertaining to the industry in India and our ability to respond to them, our ability to successfully implement our strategy, our

    development plan, our growth and expansion, technological changes, our exposure to market risks, general economic and

    political conditions in India and overseas, which have an impact on our business activities or investments, the monetary and

    fiscal policies of India and other jurisdictions, inflation, deflation, unanticipated turbulence in interest rates, foreign exchange

    rates, equity prices or other rates or prices, the performance of the financial markets in India and globally, changes in domestic

    laws, regulations and taxes, changes in competition in our industry and incidence of any natural calamities and/or acts of

    violence.

    Important factors that could cause actual results to differ materially from our expectations include the following:

    • Increased capacity due to future capacity augmentation;

    • Loss of one or more of our significant customers or a significant reduction in production and sales of, or demand for our production from our significant customers;

    • Strict quality checks and a consequent requirement to incur significant expenses to maintain such product quality;

    • Absence of any firm commitment long-term agreements with our customers;

    • Significant reliance on certain select customers and customers in application industries, in particular customers in the sectors such as pharmaceutical, agro-chemicals, refrigeration and construction chemicals;

    • Availability of raw materials on commercially acceptable terms.

    • Failure to identify and understand evolving industry trends and preferences and to develop new products to meet our customers' demands;

    • Changes in the value of the Indian rupee and other currencies;

    • Our inability to accurately forecast demand for our products, and accordingly manage our inventory or plan capacity increases;

    • Our indebtedness and the conditions and restrictions imposed on us by our financing agreements;

    • Increased costs on account of compliance with various law and regulations, in jurisdictions where we operate, including environmental and health and safety laws and regulations; and

    • Dependence on a number of key management personnel and senior management personnel.

    For a further discussion of factors that could cause our Company’s actual results to differ, please refer to the section ‘Risk

    Factors’ on page 17 and the chapters ‘Our Business’ and ‘Management’s Discussion and Analysis of Financial Condition and

  • 14

    Results of Operations’ on pages 146 and 382, respectively. By their very nature, certain market risk disclosures are only

    estimates and could be materially different from what actually occurs in the future. As a result, actual future gains or losses

    could materially differ from those that have been estimated. Neither our Company, the Selling Shareholders nor the Book

    Running Lead Manager and the Co-Book Running Lead Manager nor any of their respective affiliates or advisors has any

    obligation to update or otherwise revise any statements reflecting circumstances arising after the date hereof or to reflect the

    occurrence of underlying events, even if the underlying assumptions do not come to fruition. In accordance with regulatory

    requirements, our Company will ensure that investors in India are informed of material developments from the date of the Red

    Herring Prospectus until the date of Allotment. The Selling Shareholders will ensure that investors are informed of material

    developments in relation to the statements relating to and undertakings specifically confirmed or undertaken by it in the Red

    Herring Prospectus and the Prospectus in relation to themselves or the Offered Shares until the time of the date of Allotment.

  • 15

    PRESENTATION OF FINANCIAL, INDUSTRY AND MARKET DATA

    Certain Conventions

    All references to “India” contained in this Draft Red Herring Prospectus are to the Republic of India, all references to the “U.S.”,

    the “USA” or the “United States” are to the United States of America. Unless stated otherwise, all references to page numbers

    in this Draft Red Herring Prospectus are to the page numbers of this Draft Red Herring Prospectus.

    Financial Data

    Unless stated otherwise, the financial information in this Draft Red Herring Prospectus is derived from our Restated Financial

    Statements and comprise (a) the restated standalone financial statements expressed in Indian Rupees in millions has been

    prepared under Indian Accounting Standards (Ind As) notified by the Companies (Indian Accounting Standards) Rules, 2014,

    read with Section 133 of the Companies Act, 2013 as at and for the half year ended September 30, 2018, and Fiscals ended

    March 31, 2018, March 31, 2017, March 31, 2016, March 31, 2015 and March 31, 2014 and (b) the restated consolidated

    financial statements expressed in Indian Rupees in millions has been prepared under Indian Accounting Standards (Ind As)

    notified by the Companies (Indian Accounting Standards) Rules, 2014, read with Section 133 of the Companies Act, 2013 as

    at and for the half year ended September 30, 2018, and Fiscals ended March 31, 2018, March 31, 2017, March 31, 2016, March

    31, 2015 and March 31, 2014 and have been restated in line with the SEBI ICDR Regulations and have been reviewed and

    referred to as “Proforma Ind AS Restated Consolidated Financial Information”. For further details, please refer to the chapters

    ‘Summary Financial Information’, ‘Financial Statements’, and ‘Summary of Significant Differences between Indian GAAP and

    Ind AS’ beginning on pages 51, 198 and 378, respectively.

    Our Company’s financial year commences on April 1 and ends on March 31 of the next year and accordingly all references to

    a particular financial year, unless stated otherwise, are to the 12 months’ period ended on March 31 of that year.

    There are significant differences between Indian GAAP, IFRS and U.S. GAAP. We have not attempted to explain those

    differences or quantify their impact on the financial data included herein, and we urge you to consult your own advisors

    regarding such differences and their impact on our financial data. Accordingly, the degree to which the Restated Financial

    Information included in this Draft Red Herring Prospectus will provide meaningful information is entirely dependent on the

    reader’s level of familiarity with Indian accounting policies and practices, Ind AS, the Companies Act and the SEBI ICDR

    Regulations. Any reliance by persons not familiar with the aforementioned policies and laws on the financial disclosures

    presented in this Draft Red Herring Prospectus should accordingly be limited. Our Company does not provide a reconciliation

    of its financial statements to IFRS or U.S. GAAP financial statements. For details in connection with risks involving differences

    between Indian GAAP and other accounting principles, please refer to the section ‘Risk Factors’ on page 17.

    All numbers in this Draft Red Herring Prospectus have been presented in million or in whole numbers where the numbers have

    been too small to present in million, unless stated otherwise. One million represents 1,000,000 and one billion represents

    1,000,000,000. Figures contained in this Draft Red Herring Prospectus, including our financial statements, have been subject

    to rounding-off adjustments. All decimals have been rounded off to two decimal points. In this Draft Red Herring Prospectus,

    any discrepancies in any table between the sums of the amounts listed in the table and totals are due to rounding off.

    Unless the context requires otherwise, any percentage amounts, as set forth in this Draft Red Herring Prospectus, including in

    the section ‘Risk Factors’ on page 17 and the chapters ‘Our Business’ and ‘Management’s Discussion and Analysis of Financial

    Condition and Results of Operations’ on pages 146 and 382 respectively, have been calculated on the basis of the Restated

    Financial Statements.

    Market and Industry Data

    The chapter ‘Summary of Industry’ and ‘Industry Overview’ quotes and otherwise includes information from a commissioned

    report, or the CRISIL Report, prepared by CRISIL Research for the purposes of this Draft Red Herring Prospectus. We

    commissioned CRISIL Research to provide an independent assessment of the opportunities, dynamics and competitive

    landscape of the markets in India for the business we are engaged in.

    CRISIL has issued the CRISIL Report with the following disclaimer:

    “CRISIL Research, a division of CRISIL Limited (CRISIL) has taken due care and caution in preparing this report (Report)

    based on the Information obtained by CRISIL from sources which it considers reliable (Data). However, CRISIL does not

    guarantee the accuracy, adequacy or completeness of the Data / Report and is not responsible for any errors or omissions or

    for the results obtained from the use of Data / Report. This Report is not a recommendation to invest / disinvest in any entity

    covered in the Report and no part of this Report should be construed as an expert advice or investment advice or any form of

    investment banking within the meaning of any law or regulation. CRISIL especially states that it has no liability whatsoever to

    the subscribers / users / transmitters/ distributors of this Report. Without limiting the generality of the foregoing, nothing in the

  • 16

    Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have

    the necessary permission and/or registration to carry out its business activities in this regard. CRISIL is not, and will not be,

    responsible for ensuring compliances, and for the consequences of non-compliances, of the use of the Report or part thereof

    outside India. CRISIL Research operates independently of, and does not have access to information obtained by CRISIL’s

    Ratings Division / CRISIL Risk and Infrastructure Solutions Ltd (CRIS), which may, in their regular operations, obtain

    information of a confidential nature. The views expressed in this Report are that of CRISIL Research and not of CRISIL’s

    Ratings Division / CRIS. No part of this Report may be published/reproduced in any form without CRISIL’s prior written

    approval.”

    Except for the CRISIL Report, we have not commissioned any report for purposes of this Draft Red Herring Prospectus and

    any market and industry related data, other than that derived from the CRISIL Report, used in this Draft Red Herring Prospectus

    has been obtained or derived from publicly available documents and other industry sources.

    Industry sources and publications generally state that the information contained therein has been obtained from sources

    generally believed to be reliable, but their accuracy, completeness and underlying assumptions are not guaranteed and their

    reliability cannot be assured and accordingly, investment decisions should not be based on such information. Although we have

    no reason to believe that industry data used in this Draft Red Herring Prospectus is not reliable, it has not been independently

    verified by us, none of our Directors, the Selling Shareholders, the BRLM, the CBRLM or any of their affiliates or advisors nor

    do we make any representation as to its accuracy or completeness. The data used in these sources may have been re-classified

    by us for the purposes of presentation. Data from these sources may also not be comparable. Industry sources and publications

    are also prepared based on information as of specific dates and may no longer be current or reflect current trends. Industry

    sources and publications may also base their information on estimates, projections, forecasts and assumptions that may prove

    to be incorrect. Such data involves risks, uncertainties and numerous assumptions and is subject to change based on various

    factors, including those discussed in the section ‘Risk Factors’ on page 17. Accordingly, investors should not place undue

    reliance on, or base their investment decision on this information.

    For further details, refer to the section ‘Risk Factors’ on page 17.

    Further, the extent to which the market and industry data used in this Draft Red Herring Prospectus is meaningful depends on

    the reader’s familiarity with and understanding of the methodologies used in compiling such data. There are no standard data

    gathering methodologies in the industry in which we conduct our business, and methodologies and assumptions may vary

    widely among different industry sources. In addition, certain data in relation to our Company used in this Draft Red Herring

    Prospectus has been obtained or derived from the CRISIL Report which may differ in certain respects from our Restated

    Consolidated Financial Statements as a result of, inter alia, the methodologies used in compiling such data. Accordingly, no

    investment decision should be made based on such information.

    In accordance with the SEBI Regulations, the chapter ‘Basis for Offer Price’ on page 107 includes information relating to our

    peer companies. Such information has been derived from publicly available sources, and neither we nor the BRLM, the CBRLM

    have independently verified such information.

    Currency and Units of Presentation

    All references to ‘Rupees’ or ‘₹’ or ‘Rs.’ are to Indian Rupees, the official currency of the Republic of India.

    In this Draft Red Herring Prospectus, our Company has presented certain numerical information. All figures have been

    expressed in millions. One million represents ‘10 lakhs’ or 1,000,000. However, where any figures that may have been sourced

    from third-party industry sources are expressed in denominations other than millions, such figures appear in this Draft Red

    Herring Prospectus expressed in such denominations as provided in their respective sources.

    In this Draft Red Herring Prospectus, except the data obtained from the Restated Financial Statements, unless otherwise stated

    the USD-INR conversion rate has been taken as 1 USD = ₹ 72.5474. (Source: www.rbi.org as on September 28, 2018).

  • 17

    SECTION II: RISK FACTORS

    An investment in equity shares involves a high degree of risk. Prospective investors should carefully consider all the information

    in this Draft Red Herring Prospectus, including the risks and uncertainties described below, before making an investment in

    our Equity Shares. If any, or a combination, of the following risks materialises, our business, results of operations, cash flows

    and financial condition could suffer, the price of our Equity Shares could decline, and you may lose all or part of your

    investment. The risks and uncertainties described below are not the only risks that we currently face. Additional risks and

    uncertainties not presently known to us or that we do not, currently, believe to be material may also have an adverse effect on

    our business, results of operations, cash flows and financial condition. The financial and other related implications of risks

    concerned, wherever quantifiable, have been disclosed in the risk factors mentioned below. Unless otherwise stated in the

    relevant risk factors set forth below, we are not able to specify or quantify the financial or other risks mentioned herein.

    Investment in equity and equity related securities involves a degree of risk and Investors should not invest any funds in this

    Offer unless they can afford to take the risk of losing all or a part of their investment. In making an investment decision,

    prospective Investors must rely on their own examination of our Company and the terms of the Offer, including the risks

    involved. To obtain a complete understanding of our business, you should read the chapters ‘Our Business’, ‘Management’s

    Discussion and Analysis of Financial Condition and Result of Operations’ and ‘Financial Statements’ on pages 146, 382and

    198, respectively. If our business, result of operations or financial condition suffers, the price of the Equity Shares and the

    value of your investments in the Equity Shares could decline.

    This Draft Red Herring Prospectus also contains forward looking statements, which refers to future events that may produce

    known and unknown risks, uncertainties and other factors, many of which are beyond our control, which may cause the actual

    results to be materially different from those expressed or implied by the forward-looking statements. For further details, please

    refer to the chapter ‘Forward Looking Statements’ on page 13.

    Unless stated or context requires otherwise, the financial information of our Company used in this Section is derived from our

    Restated Consolidated Financial Statements.

    1. There are proceedings pending against our Company and our Directors which if determined against our Company or these directors, may have an adverse effect on our business and results of operations.

    There are outstanding legal proceedings involving our Company and our Directors which are pending at different

    levels of adjudication before various courts, tribunals and other authorities. The amounts claimed in these proceedings

    have been disclosed to the extent ascertainable and quantifiable and include amounts claimed jointly and severally

    from our Company and other parties. Any unfavourable decision in connection with such proceedings, individually or

    in the aggregate, could adversely affect our business and results of operations. Certain details of such outstanding legal

    proceedings as of date of this Draft Red Herring Prospectus, to the extent quantifiable, are set out below:

    Litigation involving our Company

    Nature of tax involved Number of cases

    outstanding

    Amount involved in such

    proceedings (₹ in million)

    Direct tax

    Sub-total (A) 3 2.70*

    Indirect tax

    Sub-total (B) 4 4.46**

    Total (A+B) 7 7.16*

    * To the extent quantifiable.

    ** To the extent quantifiable. In one of the matters, our Company has deposited an amount of ₹ 1.48 million, in protest,

    with the office of Commissioner of Customs.

    Litigation against our Directors

    Civil and criminal proceedings

    Particulars No. of cases Total amount

    (in ₹ million)

    Criminal proceedings 3 Nil

    Litigation against our Promoters

  • 18

    Type of direct tax No. of cases Total Amount

    (in ₹ million)

    Income Tax 1 0.1

    An unfavourable outcome in any of these proceedings could have an adverse effect our business and results of

    operations. For further details of legal proceedings involving our Company and our Directors please refer to the chapter

    ‘Outstanding Litigations and Material Developments’ on page 409.

    2. Our Company is heavily reliant on the demand from application industries such as pharmaceuticals, agrochemicals, refrigeration and construction chemicals. Any downturn in the application industries could have

    an adverse impact on our Company’s business and results of operations.

    The products manufactured by our Company find diverse uses in varied application industries including

    pharmaceuticals, agrochemicals and construction chemicals. While our products are, generally, capable of being used

    in various application industries, a significant part of our revenue from the sale of specialty chemical compounds is

    generated from sales to the pharmaceuticals industry. During the 6 month period ended September 30, 2018, Fiscal

    2018, Fiscal 2017 and Fiscal 2016, our revenue from sale of organic and inorganic chemicals to pharmaceutical

    industry was ₹762.92 million, ₹1,061.95 million, ₹ 580.71 million and ₹528.64 million, constituting 78.97%, 65.17%,

    52.47% and 52.43% of our Revenue from Operations on a consolidated basis, respectively. There can be no assurance

    that the lack of demand from any one of these industries can be off-set by sales to other industries in which our products

    find application. Accordingly, any significant downturn in the application industries could have a significant impact

    on our financial condition and our growth prospects.

    3. Our manufacturing process involves the use of hazardous and flammable industrial chemicals which entails significant risks and could also result in enhanced compliance obligations

    Our Company manufactures bromine-based compounds, lithium salts and other specialty chemical compounds such

    as chlorine, fluorine and iodine-based compounds, and, consequently, our manufacturing facilities utilises various

    hazardous and inflammable industrial chemicals such as bromine, inorganic acids such as hydrobromic acid,

    hydrochloric acid and hydrofluoric acid, flammable organic solvents, brominating and chlorinating agents and other

    corrosive raw materials. While our Company believes that it has necessary controls and processes in place, any failure

    of such systems, mishandling of hazardous chemicals or any adverse incident related to the use of these chemicals or

    otherwise during the manufacturing process may cause industrial accidents, fire, loss of human life, damage to our and

    third-party property and, or, environmental damage. If any industrial accident, loss of human life or environmental

    damage were to occur we could be subject to significant penalties, other actionable claims and, in some instances,

    criminal prosecution. Any such event would in addition to adversely affecting our reputation also temporarily reduce

    our manufacturing capacity which could adversely affect our business, results of operations and reputation.

    Further, any environmental damages could increase the regulatory scrutiny and result in enhanced compliance

    requirements including on use of materials and effluent treatment which would, amongst others, increase the cost of

    our operations.

    4. Our Company is heavily reliant on certain customers and significant part of our revenue is generated from select clients and we do not have long term contracts with these customers.

    Our Company manufactures organic including bromine-based compounds and other specialty chemical compounds

    such as chlorine, fluorine and iodine-based compounds and Grignard reagents. Our specialty organic chemical

    compounds find application in user industries such as pharmaceutical, agrochemical, aroma chemical and electronic-

    chemical. In addition, we also manufacture inorganic chemicals comprising lithium salts. Lithium salts find

    application, primarily as refrigeration agents, and are sold to refrigeration OEMs. Lithium salts also find application

    in pharmaceutical, specialty polymer and construction chemicals industries.

    During the 6 month period ended September 30, 2018, Fiscal 2018, Fiscal 2017 and Fiscal 2016, our revenue from

    organic chemicals was ₹ 685.13 million, ₹1,056.23 million, ₹ 634.20 million and ₹ 732.18 million, constituting

    70.91%, 64.82%, 57.30% and 72.62% of our Revenue from Operations on a consolidated basis, respectively,.

    Moreover, during the 6 month period ended September 30, 2018, Fiscal 2018, Fiscal 2017 and Fiscal 2016, our revenue

    from inorganic chem